Chlorasquin inhibits thymidylate synthetase with an approximate K i value of 4.9 μM. Chlorasquin is also a folate antagonist, testing the Methotrexate ( HY-14519 ) effect. Chlorasquin binds tighter to dihydrofolate reductase at alkaline pH than does Methotrexate , which is promising for research of antipsoriatic agents.
Products | Products > Disease Areas > Others | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Others | Products > Signaling Pathways > Thymidylate Synthase | Products > Signaling Pathways > Antifolate | Products > Signaling Pathways > Dihydrofolate reductase (DHFR)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.